Skip to Main content Skip to Navigation
Journal articles

Adjuvant Radioimmunotherapy Trial with Iodine-131-Labeled Anti-Carcinoembryonic Antigen Monoclonal Antibody F6 F(ab')2 after Resection of Liver Metastases from Colorectal Cancer.

Abstract : PURPOSE: To evaluate the feasibility of radioimmunotherapy (RIT) with radiolabeled anti-carcinoembryonic antigen antibodies after complete resection of liver metastases (LM) from colorectal cancer. Patients and Methods: Twenty-two patients planned for surgery of one to four LM received a preoperative diagnostic dose of a (131)I-F(ab')(2)-labeled anti-carcinoembryonic antigen monoclonal antibody F6 (8-10 mCi/5 mg). (131)I-F(ab')(2) uptake was analyzed using direct radioactivity counting, and tumor-to-normal liver ratios were recorded. Ten patients with tumor-to-normal liver ratios of >5 and three others were treated with a therapeutic injection [180-200 mCi (131)I/50 mg F(ab')(2)] 30 to 64 days after surgery. RESULTS: Median (131)I-F(ab')(2) immunoreactivity in patient serum remained at 91% of initial values for up to 96 hours after injection. The main and dose-limiting-toxicity was hematologic, with 92% and 85% grades 3 to 4 neutropenia and thrombocytopenia, respectively. Complete spontaneous recovery occurred in all patients. No human anti-mouse antibody response was observed after the diagnosis dose; however, 10 of the 13 treated patients developed human anti-mouse antibody approximately 3 months later. Two treated patients presented extrahepatic metastases at the time of RIT (one bone and one abdominal node) and two relapsed within 3 months of RIT (one in the lung and the other in the liver). Two patients are still alive, and one of these is disease-free at 93 months after resection. At a median follow-up of 127 months, the median disease-free survival is 12 months and the median overall survival is 50 months. CONCLUSION: RIT is feasible in an adjuvant setting after complete resection of LM from colorectal cancer and should be considered for future trials, possibly in combination with chemotherapy, because of the generally poor prognosis of these patients.
Document type :
Journal articles
Complete list of metadatas

Cited literature [20 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00292535
Contributor : Yves Le Ster <>
Submitted on : Tuesday, June 2, 2009 - 4:22:08 PM
Last modification on : Monday, July 20, 2020 - 12:34:51 PM
Long-term archiving on: : Friday, May 28, 2010 - 11:03:01 PM

Identifiers

Collections

Citation

Marc Ychou, David Azria, Cathy Menkarios, Patrick Faurous, François Quenet, et al.. Adjuvant Radioimmunotherapy Trial with Iodine-131-Labeled Anti-Carcinoembryonic Antigen Monoclonal Antibody F6 F(ab')2 after Resection of Liver Metastases from Colorectal Cancer.. Clinical Cancer Research, American Association for Cancer Research, 2008, 14 (11), pp.3487-93. ⟨10.1158/1078-0432.CCR-07-4698⟩. ⟨inserm-00292535⟩

Share

Metrics

Record views

487

Files downloads

950